NOUVEAUX COMPOSES OU SELS DE CEUX-CI ACCEPTABLES SUR LE PLAN PHARMACEUTIQUE UTILISES EN TANT QU'ANTAGONISTES DE RECEPTEUR VANILLOIDE; ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES
This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salt thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.